Advanced search
Publication Cover
Expert Review of Anticancer Therapy Volume 18, 2018 - Issue 11
Submit an article Journal homepage
467
Views
2
CrossRef citations to date
0
Altmetric
Review

The role of tivozanib in advanced renal cell carcinoma therapy

Bernard EscudierDepartment of Oncological Medicine, Institut Gustave Roussy, Villejuif, FranceView further author information
,
Camillo PortaMedical Oncology, University of Pavia and La Istituti Clinici Scientifici Maugeri, Pavia, ItalyView further author information
,
Tim EisenDepartment of Oncology, Cambridge University Health Partners, Cambridge, UKView further author information
,
Jonathan BelseyJB Medical Ltd, Sudbury, UKView further author information
,
Damilola GibsonMedical Affairs, EUSA Pharma, Hemel Hempstead, UKView further author information
,
Jonathan MorganMedical Affairs, EUSA Pharma, Hemel Hempstead, UKCorrespondence[email protected]
View further author information
&
Robert MotzerGenitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USAView further author information
 show all
Pages 1113-1124 | Received 20 Mar 2018, Accepted 02 Aug 2018, Published online: 21 Aug 2018

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Jonathan Chatzkel, Brian Ramnaraign & Guru Sonpavde. (2022) Tivozanib for the treatment of advanced renal cell carcinoma. Expert Opinion on Pharmacotherapy 23:10, pages 1135-1142.
Read now
Suresh Gopi Kalathil, Katy Wang, Alan Hutson, Renuka Iyer & Yasmin Thanavala. (2020) Tivozanib mediated inhibition of c-Kit/SCF signaling on Tregs and MDSCs and reversal of tumor induced immune suppression correlates with survival of HCC patients. OncoImmunology 9:1.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.